Autopsy report · NCT02393716
Endurant Evo US Clinical Trial
Cause of deathDrug or device supply
“This study terminated enrollment due to device failures prior to enrollment completion.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 6 years 2 months before it stopped.
- 139 participants enrolled.
- Results were posted on the registry 1 year 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Medtronic Cardiovascular
- Sponsor type
- Industry
- Conditions
- Abdominal Aortic Aneurysm; AAA
- Interventions
- Endurant Evo AAA Stent Graft System; Endovascular aneurysm repair (EVAR)
- Participants
- 139
- Sites
- 14
- Countries
- United States
Trials that died the same way
- Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
“The study was terminated because of significant enrollment challenges” - A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
“This study was terminated early due to poor enrollment.” - The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
“This study was prematurely terminated due to low enrollment” - Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
“the study was terminated early due to poor enrollment” - The Effect of Blended Sensor Efficiency on Relieving the Heart's Inability to Increase Its Rate During Exercise
“The study was terminated due to poor enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.